Paratome: an online tool for systematic identification of antigen-binding regions in antibodies based on sequence or structure
- PMID: 22675071
- PMCID: PMC3394289
- DOI: 10.1093/nar/gks480
Paratome: an online tool for systematic identification of antigen-binding regions in antibodies based on sequence or structure
Abstract
Antibodies are capable of specifically recognizing and binding antigens. Identification of the antigen-binding site, commonly dubbed paratope, is of high importance both for medical and biological applications. To date, the identification of antigen-binding regions (ABRs) relies on tools for the identification of complementarity-determining regions (CDRs). However, we have shown that up to 22% of the residues that actually bind the antigen fall outside the traditionally defined CDRs. The Paratome web server predicts the ABRs of an antibody, given its amino acid sequence or 3D structure. It is based on a set of consensus regions derived from a structural alignment of a non-redundant set of all known antibody-antigen complexes. Given a query sequence or structure, the server identifies the regions in the query antibody that correspond to the consensus ABRs. An independent set of antibody-antigen complexes was used to test the server and it was shown to correctly identify at least 94% of the antigen-binding residues. The Paratome web server is freely available at http://www.ofranlab.org/paratome/.
Figures
References
-
- Chan AC, Carter PJ. Therapeutic antibodies for autoimmunity and inflammation. Nat. Rev. 2010;10:301–316. - PubMed
-
- Verhoeyen M, Milstein C, Winter G. Reshaping human antibodies: grafting an antilysozyme activity. Science. 1988;239:1534–1536. - PubMed
-
- Almagro JC. Identification of differences in the specificity-determining residues of antibodies that recognize antigens of different size: implications for the rational design of antibody repertoires. J. Mol. Recognit. 2004;17:132–143. - PubMed
-
- Lou J, Marks JD. Affinity maturation by chain shuffling and site directed mutagenesis. In: Kontermann F, Dübel S, editors. Antibody Engineering, Part IV. Springer Berlin Heidelberg: 2010. pp. 377–396.
-
- Schrama D, Reisfeld RA, Becker JC. Antibody targeted drugs as cancer therapeutics. Nat. Rev. Drug Discov. 2006;5:147–159. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
